BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Muhammed Y, Yusuf Nadabo A, Pius M, Sani B, Usman J, Anka Garba N, Mohammed Sani J, Opeyemi Olayanju B, Zeal Bala S, Garba Abdullahi M, Sambo M. SARS-CoV-2 spike protein and RNA dependent RNA polymerase as targets for drug and vaccine development: A review. Biosaf Health 2021;3:249-63. [PMID: 34396086 DOI: 10.1016/j.bsheal.2021.07.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Cetinkaya A, Kaya SI, Ozkan SA. A Comprehensive Overview of Sensors Applications for the Diagnosis of SARS-CoV-2 and of Drugs Used in its Treatment. Crit Rev Anal Chem 2023;:1-21. [PMID: 36877165 DOI: 10.1080/10408347.2023.2186693] [Reference Citation Analysis]
2 Algar-Lizana S, Bonache MÁ, González-Muñiz R. SARS-CoV-2 main protease inhibitors: What is moving in the field of peptides and peptidomimetics? J Pept Sci 2022;:e3467. [PMID: 36479966 DOI: 10.1002/psc.3467] [Reference Citation Analysis]
3 Ivanova YO, Voronina AI, Skvortsov VS. [The prediction of SARS-CoV-2 main protease inhibition with filtering by position of ligand]. Biomed Khim 2022;68:444-58. [PMID: 36573412 DOI: 10.18097/PBMC20226806444] [Reference Citation Analysis]
4 Cervantes-Torres J, Rosales-Mendoza S, Cabello C, Montero L, Hernandez-Aceves J, Granados G, Calderón-Gallegos A, Zúñiga-Flores F, Ruiz-Rivera M, Abarca-Magaña JC, Ortega-Francisco S, Olguin-Alor R, Díaz G, Paczka-Garcia F, Zavala-Gaytan R, Vázquez-Ramírez R, Ayón-Nuñez DA, Carrero JC, Rios D, Jasso-Ramírez M, Vázquez-Hernández R, Venegas D, Garzón D, Cobos L, Segura-Velázquez R, Villalobos N, Meneses G, Zúñiga J, Gamba G, Cárdenas G, Hernández M, Parkhouse ME, Romano MC, Alonso Herrera L, Bobes RJ, Pérez-Tapia M, Huerta L, Fierro N, Gracia I, Soldevilla G, Fragoso G, Suárez-Güemes F, Laclette JP, Sciutto E. Towards the development of an epitope-focused vaccine for SARS-CoV-2. Vaccine 2022;40:6489-98. [PMID: 36195474 DOI: 10.1016/j.vaccine.2022.09.059] [Reference Citation Analysis]
5 Wahongan IF, Suoth EJ, Fatimawali, Alhumaid S, Albayat H, Aljeldah M, Al Shammari BR, Mashraqi MM, Alshehri AA, Sulaiman T, Turkistani SA, Alwashmi ASS, Garout M, Tallei TE, Rabaan AA. Designing an Epitope-Based Peptide Vaccine Derived from RNA-Dependent RNA Polymerase (RdRp) against Dengue Virus Serotype 2. Vaccines 2022;10:1734. [DOI: 10.3390/vaccines10101734] [Reference Citation Analysis]
6 Shen Y, Eades W, Liu W, Yan B. The COVID-19 Oral Drug Molnupiravir Is a CES2 Substrate: Potential Drug-Drug Interactions and Impact of CES2 Genetic Polymorphism In Vitro. Drug Metab Dispos 2022;50:1151-60. [PMID: 35790245 DOI: 10.1124/dmd.122.000918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang K, Wang K, Zhang C, Teng X, Li D, Chen M. Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses. BMC Cancer 2022;22:687. [PMID: 35733175 DOI: 10.1186/s12885-022-09763-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Yang J, Lin S, Sun H, Chen Z, Yang F, Lin X, Guo L, Wang L, Wen A, Zhang X, Dai Y, He B, Cao Y, Dong H, Liu X, Chen B, Li J, Zhao Q, Lu G. A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding. Front Immunol 2022;13:820336. [PMID: 35663966 DOI: 10.3389/fimmu.2022.820336] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Alagheband Bahrami A, Azargoonjahromi A, Sadraei S, Aarabi A, Payandeh Z, Rajabibazl M. An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19). Cell Mol Biol Lett 2022;27:38. [PMID: 35562685 DOI: 10.1186/s11658-022-00339-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Mahmoudi S, Dehkordi MM, Asgarshamsi MH. The effect of various compounds on the COVID mechanisms, from chemical to molecular aspects. Biophysical Chemistry 2022. [DOI: 10.1016/j.bpc.2022.106824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ohanube GAK, Obeta UM. Generation of mRNA Vaccine: An Analysis of Two Types of Vectors. Int j pharm phytopharm res 2021;11:24-32. [DOI: 10.51847/0nhpnuouhg] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]